The unit joins the group laboratories (MedLife Grivita, MedLife Brasov, Panduri Laboratory and others) that already provide lab services.
“This is the first step of the expansion and development project approved by the shareholders a few months ago. A sustained period of acquisitions will follow, at the end of which we want to consolidate our leading position,” said Mihai Marcu, President and CEO of MedLife Group.
Onco Team Diagnostic Laboratory, located in Bucharest and with over 6 years of activity on the market, is one of the reference laboratories for this segment, providing patients with a fully automatic system of pathology, immunohistochemistry and molecular biology.
It is one of the relevant providers of laboratory services under contract with the Health Insurance House of Bucharest (CASMB), as well as the Health Insurance Houses of counties Arges and Dambovita.
“This partnership is primarily a medical partnership, our patients will benefit from multidisciplinarity. At the same time, it is also a great opportunity to develop our business, thus benefiting from all the strategy and support of the group in the medical and management areas. We will take an important step in the evolution of the company, and in this way we will advance in the complexity and efficiency of the medical act, ensuring clinico-pathological diagnoses of a high accuracy,” said Adina Balan, one of the shareholders of the laboratory
According to company representatives, Onco Team Diagnostic Laboratory had a turnover of EUR1.1 million in 2018.